1st Quarter - Report

THE DUBERSTEIN GROUP INC. for PFIZER INC.

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Deficit reduction efforts - Proposed legislation re this issue.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
MARTI THOMAS —
ERIC UELAND —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Corporate tax reform, including international taxes and tax extenders - Proposed legislation re these issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
ERIC UELAND —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

FDA user fee agreements - Proposed legislation re this issue. Incentives to developing antibiotics - HR 2182, Generating Antibiotic Incentives Now Act of 2011; S 1734, Generating Antibiotic Incentives Now Act of 2011. Bulletin on essential benefits - Executive Branch action re this issue. Encourage the discovery and development of new treatments for patients with chronic or rare diseases - HR 3497, MODDERN Cures Act of 2011. Repeal Independent Payment Advisory Board provision of PL 111-148, PL 111-152 - HR 452, Medicare Decisions Accountability Act of 2011; HR 5, Protecting Access to Healthcare Act; S 2118, Health Care Bureaucrats Elimination Act.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
MARTI THOMAS —
ERIC UELAND —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3497 (112th), H.R. 452 (112th), H.R. 5 (112th), H.R. 2182 (112th)

Medicare/Medicaid MMM

Sustainable growth rate and impact on other Medicare programs, medicare physician payment, budget offsets - HR 3630, Temporary Payroll Tax Cut Continuation Act of 2011.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
MARTI THOMAS —
ERIC UELAND —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3630 (112th)

Pharmacy PHA

Addressing drug shortages, including enhanced evaluation of companies and manufacturing sites, real-cause analysis, inventory at companies, improving quality control processes - Proposed legislation re these issues. Opiate abuse issues - Proposed legislation re this issue. Tracking and tracing medicines - Proposed legislation re this issue. Antidote for exposure to chemical agents - Executive Branch action re this issue.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
MARTI THOMAS —
ERIC UELAND —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.